Hi Everyone,
The long awaited pick is finally here. PRTN is our brand new pick of the (end of) summer, and we think this pick could be as good as our last medical-sector pick (which soared to over $2) from an alert at right around 30 cents.
Premium Members had the opportunity to come in at the market open earlier today and have already secured gains of about 50% (so for next time if you would like the same opportunity head over to PremiumStockReport dot com and sign up now).
In the interim you may still be able to benefit from a jump to over $2 which is a very respectable 600% + in gains from current levels.
PRTN announced this morning the completion of the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.
Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.
The drug indication, that Eaton Scientific named Tropine 3, is currently being prescribed and compounded by doctors in the Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment. The drug, homatropine, is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, and as a mydriatic in order to dilate the pupil. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic administration.
Homatropine has been prescribed continuously and safely in the United States for over 40 years."Every woman who has experienced hot flashes knows the devastating affects they have on themselves personally and on their loved ones.
Tropine 3 has been shown in individual cases to reduce the symptoms of hot flashes in terms of intensity, duration, and number of occurrences without the use of dangerous hormones which," said Michael Borkowski, CEO and President of Eaton Scientific Systems, Ltd. "We look forward to building market awareness and acceptance of Tropine 3 throughout the women's health care sector in hopes of improving the lives of the over 50 million women in America that would benefit from this proven safe and effective treatment for hot flashes."
The Company is currently assembling a senior management team and group of scientific advisors to assist in the ongoing development and clinical testing of Tropine 3. Clinical trials currently being contemplated will be performed to strict FDA standards to provide support to claims made in Eaton Scientific's patent filed under USPTO #60/719,756. Additional information regarding the near-term scheduling and commencement of planned Tropine 3 clinical trials will be made available in subsequent public statements.
You can visit the company's site at EatonScientific dot com
Our most successful picks in history have always been in the biotech/biomed sector and we really think that PRTN will be no exception to that rule.
Moreover September has also historically been the month where our picks perform better and we anticipate that PPRTN could be trading at MUCH higher than today come mid-end September.
We plan on covering this great company for many weeks to come as it seems like there's a lot of exciting things going on there, and we want to see the story develop more.
Important Pharmaceutical companies have always soared after FDA approval of their drugs and PRTN could do the same should clinical trials of Tropine 3 be successful and the FDA approves it.
In fact we saw a "pennystock" (on pinksheet) soar more than 2,000% after the FDA approved a drug it had worked on. The company was TTNP it went from 3 cents to more than $2 about 36 months ago. It soared in less than 30 days. and is still sitting at around $1 even today!
That's the type of enormous positive effect an FDA approval can have on a stock as it creates millionaires virtually overnight.
Watch PRTN very closely over the next few weeks as enormous things could be on the agenda!
Happy Trading,
Your Pennystocks123 Editor.
